###begin article-title 0
Cell fusions in mammals
###end article-title 0
###begin p 1
Cell fusions are important to fertilization, placentation, development of skeletal muscle and bone, calcium homeostasis and the immune defense system. Additionally, cell fusions participate in tissue repair and may be important to cancer development and progression. A large number of factors appear to regulate cell fusions, including receptors and ligands, membrane domain organizing proteins, proteases, signaling molecules and fusogenic proteins forming alpha-helical bundles that bring membranes close together. The syncytin family of proteins represent true fusogens and the founding member, syncytin-1, has been documented to be involved in fusions between placental trophoblasts, between cancer cells and between cancer cells and host cells. We review the literature with emphasis on the syncytin family and propose that syncytins may represent universal fusogens in primates and rodents, which work together with a number of other proteins to regulate the cell fusion machinery.
###end p 1
###begin title 2
Keywords
###end title 2
###begin title 3
Cell fusions in the developing mammal
###end title 3
###begin p 4
###xml 208 212 208 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR69">2005</xref>
###xml 115 118 <span type="species:ncbi:9606">man</span>
###xml 312 315 <span type="species:ncbi:9606">man</span>
The fusion between the sperm and the egg marks the beginning of a new individual and ensuing development of either man or beast depends upon a number of additional cell fusion events (reviewed by Ogle et al. 2005). Thus, mononuclear cytotrophoblasts fuse to form the syncytiotrophoblast layer of the placenta in man and certain other mammals. Syncytiotrophoblasts control the exchange of gases, nutrients and waste products between the fetus and the mother, protect the fetus against the maternal immune system and are also responsible for the production of hormones, which like chorionic gonadotropin, regulate the continuation of pregnancy. In addition, in the developing individual, myoblasts fuse to form multinucleated skeletal muscle fibers, while cells of monocytic origin fuse to form osteoclasts, which participate in bone sculpturing and remodeling as well as in the regulation of serum calcium concentrations.
###end p 4
###begin title 5
Cell fusions contribute to tissue repair
###end title 5
###begin p 6
###xml 116 120 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">1994</xref>
###xml 281 285 281 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR86">2005</xref>
###xml 405 409 405 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR85">2003</xref>
###xml 423 427 423 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR89">2003</xref>
###xml 669 673 669 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">2003</xref>
###xml 688 692 688 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR75">2006</xref>
###xml 714 718 714 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR85">2003</xref>
###xml 732 736 732 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR89">2003</xref>
###xml 946 950 946 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR86">2005</xref>
###xml 1138 1142 1138 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR86">2005</xref>
###xml 1291 1295 1291 1295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR75">2006</xref>
###xml 1689 1693 1689 1693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR75">2006</xref>
###xml 1761 1765 1761 1765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR47">1999</xref>
###xml 1792 1796 1792 1796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">1999</xref>
###xml 2036 2040 2036 2040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR71">2007</xref>
###xml 2178 2182 2178 2182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR47">1999</xref>
###xml 1200 1204 <span type="species:ncbi:10090">mice</span>
###xml 1319 1323 <span type="species:ncbi:10090">mice</span>
###xml 1670 1674 <span type="species:ncbi:10090">mice</span>
It is well-known that skeletal muscle is regenerated through fusion of muscle fibers with satellite cells (Bischoff 1994) and that macrophages may fuse to form multinucleated giant cells with enhanced phagocytic capabilities in response to injury and antigenic challenges (Vignery 2005). Recent data indicate that additional cell fusions may contribute to tissue repair in the adult (Vassilopoulos et al. 2003; Wang et al. 2003). Bone-marrow-derived (BMD) cells have been shown to fuse with hepatic cells, nerve cells and gastrointestinal cells and the theory has been put forward that such fusions may serve to repair damaged or corrupted cells (Alvarez-Dolado et al. 2003; Rizvi et al. 2006; Vassilopoulos et al.2003; Wang et al. 2003). However, it is still debated whether such fusions are important to tissue repair and whether they engage BMD stem cells or more differentiated fusogenic cells like monocytes/macrophages (reviewed by Vignery 2005). Intriguingly, the accumulation of macrophages in injured organs may reflect not only the need to remove debris but also to repair compromised cells through heterotypic fusions (Vignery 2005). Moreover, in recent transplant experiments, irradiated mice showed evidence of fusions between crypt stem cells and donor BMD cells (Rizvi et al. 2006). In thus transplanted mice, representatives of all cell lineages derived from intestinal crypt stem cells (absorptive columnar, enteroendocrine, goblet and Paneth cells) showed expression of chromosomal markers characterizing donor BMD cells. This phenomenon appeared to depend upon tissue injury since expression of donor cell markers never was detected in non-irradiated mice (Rizvi et al. 2006). An alternative to fusions has been suggested by Holmgren et al. (1999) and de la Taille et al. (1999), who have demonstrated that cells phagocytosing apoptotic cells may acquire functional DNA. Moreover, a mechanism of cell-cell invasion (entosis) was recently described and could potentially transfer DNA between cells (Overholtzer et al. 2007). Thus, viral as well as normal sequences from apoptotic cells have been found to be active also in phagocytosing cells (Holmgren et al. 1999). This observation challenges our understanding of apoptosis as an efficient way of clearing corrupted or alien DNA.
###end p 6
###begin title 7
Cell fusions during viral infections
###end title 7
###begin p 8
###xml 693 697 693 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR55">2003</xref>
###xml 42 47 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Infections with enveloped viruses such as HIV-1 may also lead to cell fusions. The viral genome encodes envelope (Env) proteins, which bind to cell surface receptors and assist the virus in entering the cell. The infected cell commences to synthesize Env proteins, which, upon insertion in the plasmalemma, engages receptor proteins in neighboring cells and initiate fusions. Interestingly, modifications of the cytoplasmic tail of several Env proteins appear to modify fusions. Thus, proteolytic cleavage of the cytoplasmic tail regulates fusions and also cellular signaling events, such as tyrosine kinase activity, may be involved in regulation of virally induced cell fusions (Kubo et al. 2003).
###end p 8
###begin p 9
###xml 1141 1145 1141 1145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">2005</xref>
Receptor proteins may bind Env proteins from different classes of viruses. Thus, a cell infected by a specific virus becomes resistant to infections with other viruses that bind to the same receptor. This phenomenon, which probably reflects receptor saturation, has led to the grouping of retroviruses into different subtypes, which bind to the same receptor. Other types of viruses encode fusogenic proteins (like influenza hemagglutinin), which do not bind to surface receptors, but which liberate a fusion peptide in the acidic milieu of endosomes and thus initiate viral-host cell fusion following endocytic uptake of viral particles. Both these proteins and the Env proteins are referred to as class I viral fusion proteins and contain hydrophobic fusion peptides buried within their sequences. Following receptor engagement or endosomal acidification the fusion peptides are liberated by proteolytic cleavage. The cleaved peptides undergo conformational changes, resulting in hairpin-like, alpha-helical bundles, which bring the viral and cell membranes into close apposition and thereby facilitates fusion (reviewed by Chen and Olson 2005).
###end p 9
###begin title 10
Cancer-host cell fusions
###end title 10
###begin p 11
###xml 3 7 3 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">1911</xref>
###xml 376 380 376 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">1962</xref>
###xml 396 400 396 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">2002</xref>
###xml 419 423 419 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR68">2004</xref>
###xml 441 445 441 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR87">1994</xref>
###xml 454 455 454 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 457 458 457 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 460 461 460 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 528 532 528 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">2003</xref>
###xml 553 557 553 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">2000</xref>
###xml 574 578 574 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">1990</xref>
###xml 594 598 594 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR52">1983</xref>
###xml 615 620 615 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR56">1984a</xref>
###xml 636 641 636 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR88">1974a</xref>
###xml 643 644 643 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR90">b</xref>
###xml 674 678 674 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR37">1974</xref>
###xml 701 705 701 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR36">1982</xref>
###xml 724 728 724 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR68">2004</xref>
###xml 817 818 817 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 1143 1147 1143 1147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR37">1974</xref>
###xml 1166 1170 1166 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR68">2004</xref>
###xml 1186 1191 1186 1191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR88">1974a</xref>
###xml 1193 1194 1193 1194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR90">b</xref>
###xml 1203 1204 1203 1204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 1206 1207 1206 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 1228 1232 1228 1232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR68">2004</xref>
###xml 1412 1413 1412 1413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 1513 1514 1513 1514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 1623 1624 1623 1624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 1769 1770 1769 1770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 1927 1931 1927 1931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">2007</xref>
###xml 1952 1956 1952 1956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">2004</xref>
###xml 1972 1976 1972 1976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR94">2005</xref>
###xml 1994 1998 1994 1998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR80">2004</xref>
###xml 2180 2184 2180 2184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">2004</xref>
###xml 2200 2204 2200 2204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR94">2005</xref>
###xml 2439 2443 2439 2443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">2007</xref>
###xml 2568 2572 2568 2572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR80">2004</xref>
###xml 2818 2822 2818 2822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR73">2005</xref>
###xml 2825 2831 2825 2831 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 2955 2960 2955 2960 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HUVEC</italic>
###xml 3022 3025 3022 3025 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 3027 3028 3027 3028 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 3069 3074 3069 3074 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 3076 3077 3076 3077 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 3102 3106 3102 3106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 3108 3109 3108 3109 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 3138 3139 3138 3139 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 3216 3229 3216 3229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">orange-yellow</italic>
###xml 2831 3230 2831 3230 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="12">Cancer&#8211;endothelial cell fusion. Co-culture of human breast cancer (MCF-7) cells and human umbilical vein endothelial cells (<italic>HUVEC</italic>). Cells were stained for the cancer cell marker cytokeratin (<italic>red</italic>, <bold>c</bold>), the endothelial cell marker vimentin (<italic>green</italic>, <bold>b</bold>) and DNA (bisbenzimide, <italic>blue</italic>, <bold>d</bold>). Note in the merged image (<bold>a</bold>) one fused, multinucleated cell reacting for both cytokeratin and vimentin (<italic>orange-yellow</italic>)</p>
###xml 2831 3230 2831 3230 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="12">Cancer&#8211;endothelial cell fusion. Co-culture of human breast cancer (MCF-7) cells and human umbilical vein endothelial cells (<italic>HUVEC</italic>). Cells were stained for the cancer cell marker cytokeratin (<italic>red</italic>, <bold>c</bold>), the endothelial cell marker vimentin (<italic>green</italic>, <bold>b</bold>) and DNA (bisbenzimide, <italic>blue</italic>, <bold>d</bold>). Note in the merged image (<bold>a</bold>) one fused, multinucleated cell reacting for both cytokeratin and vimentin (<italic>orange-yellow</italic>)</p></caption>
###xml 3230 3230 3230 3230 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="418_2008_411_Fig1_HTML" id="MO1"/>
###xml 2825 3230 2825 3230 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="12">Cancer&#8211;endothelial cell fusion. Co-culture of human breast cancer (MCF-7) cells and human umbilical vein endothelial cells (<italic>HUVEC</italic>). Cells were stained for the cancer cell marker cytokeratin (<italic>red</italic>, <bold>c</bold>), the endothelial cell marker vimentin (<italic>green</italic>, <bold>b</bold>) and DNA (bisbenzimide, <italic>blue</italic>, <bold>d</bold>). Note in the merged image (<bold>a</bold>) one fused, multinucleated cell reacting for both cytokeratin and vimentin (<italic>orange-yellow</italic>)</p></caption><graphic position="anchor" xlink:href="418_2008_411_Fig1_HTML" id="MO1"/></fig>
###xml 3230 3236 3230 3236 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;2</label>
###xml 3411 3415 3411 3415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FISH</italic>
###xml 3465 3470 3465 3470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 3472 3473 3472 3473 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 3475 3476 3475 3476 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 3478 3479 3478 3479 <bold xmlns:xlink="http://www.w3.org/1999/xlink">l</bold>
###xml 3508 3511 3508 3511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 3513 3514 3513 3514 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 3516 3517 3516 3517 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h</bold>
###xml 3519 3520 3519 3520 <bold xmlns:xlink="http://www.w3.org/1999/xlink">m</bold>
###xml 3561 3565 3561 3565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 3567 3568 3567 3568 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 3570 3571 3570 3571 <bold xmlns:xlink="http://www.w3.org/1999/xlink">i</bold>
###xml 3573 3574 3573 3574 <bold xmlns:xlink="http://www.w3.org/1999/xlink">n</bold>
###xml 3628 3631 3628 3631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DIC</italic>
###xml 3633 3634 3633 3634 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 3636 3637 3636 3637 <bold xmlns:xlink="http://www.w3.org/1999/xlink">j</bold>
###xml 3639 3640 3639 3640 <bold xmlns:xlink="http://www.w3.org/1999/xlink">o</bold>
###xml 3650 3659 3650 3659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red-green</italic>
###xml 3680 3681 3680 3681 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 3683 3684 3683 3684 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 3686 3687 3686 3687 <bold xmlns:xlink="http://www.w3.org/1999/xlink">k</bold>
###xml 3789 3790 3789 3790 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 3791 3792 3791 3792 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 4019 4020 4019 4020 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 4021 4022 4021 4022 <bold xmlns:xlink="http://www.w3.org/1999/xlink">j</bold>
###xml 4151 4152 4151 4152 <bold xmlns:xlink="http://www.w3.org/1999/xlink">k</bold>
###xml 4153 4154 4153 4154 <bold xmlns:xlink="http://www.w3.org/1999/xlink">o</bold>
###xml 3236 4155 3236 4155 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="13">Chromosomal markers and cell fusions. Co-cultures of human breast cancer cells and bovine endothelial cells. The cultures were subjected to fluorescent in situ hybridization (<italic>FISH</italic>) with probes recognizing all bovine chromosomes (<italic>green</italic>; <bold>b</bold>, <bold>g</bold>, <bold>l</bold>) and all human chromosomes (<italic>red</italic>; <bold>c</bold>, <bold>h</bold>, <bold>m</bold>) and counter-stained for DNA with DAPI (<italic>blue</italic>; <bold>d</bold>, <bold>i</bold>, <bold>n</bold>) and observed in differential interference contrast (<italic>DIC</italic>; <bold>e</bold>, <bold>j</bold>, <bold>o</bold>). Merged <italic>red-green</italic> images are shown in <bold>a</bold>, <bold>f</bold>, <bold>k</bold>. Note that initially, binuclear cells (heterokaryons) form, having one bovine and one human nucleus (<bold>a</bold>&#8211;<bold>e</bold>). Occasionally, tri- or multinuclear cells with different admixtures of bovine and human nuclei are also detected. At longer times after mixing, mitotic figures, containing an admixture of bovine and human chromosomes appear (<bold>f</bold>&#8211;<bold>j</bold>) and, eventually, cells with a single nucleus, containing an admixture of the two genomes in mixture (synkaryons) are detected (<bold>k</bold>&#8211;<bold>o</bold>)</p>
###xml 3236 4155 3236 4155 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="13">Chromosomal markers and cell fusions. Co-cultures of human breast cancer cells and bovine endothelial cells. The cultures were subjected to fluorescent in situ hybridization (<italic>FISH</italic>) with probes recognizing all bovine chromosomes (<italic>green</italic>; <bold>b</bold>, <bold>g</bold>, <bold>l</bold>) and all human chromosomes (<italic>red</italic>; <bold>c</bold>, <bold>h</bold>, <bold>m</bold>) and counter-stained for DNA with DAPI (<italic>blue</italic>; <bold>d</bold>, <bold>i</bold>, <bold>n</bold>) and observed in differential interference contrast (<italic>DIC</italic>; <bold>e</bold>, <bold>j</bold>, <bold>o</bold>). Merged <italic>red-green</italic> images are shown in <bold>a</bold>, <bold>f</bold>, <bold>k</bold>. Note that initially, binuclear cells (heterokaryons) form, having one bovine and one human nucleus (<bold>a</bold>&#8211;<bold>e</bold>). Occasionally, tri- or multinuclear cells with different admixtures of bovine and human nuclei are also detected. At longer times after mixing, mitotic figures, containing an admixture of bovine and human chromosomes appear (<bold>f</bold>&#8211;<bold>j</bold>) and, eventually, cells with a single nucleus, containing an admixture of the two genomes in mixture (synkaryons) are detected (<bold>k</bold>&#8211;<bold>o</bold>)</p></caption>
###xml 4155 4155 4155 4155 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="418_2008_411_Fig2_HTML" id="MO2"/>
###xml 3230 4155 3230 4155 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig2"><label>Fig.&#160;2</label><caption><p textid="13">Chromosomal markers and cell fusions. Co-cultures of human breast cancer cells and bovine endothelial cells. The cultures were subjected to fluorescent in situ hybridization (<italic>FISH</italic>) with probes recognizing all bovine chromosomes (<italic>green</italic>; <bold>b</bold>, <bold>g</bold>, <bold>l</bold>) and all human chromosomes (<italic>red</italic>; <bold>c</bold>, <bold>h</bold>, <bold>m</bold>) and counter-stained for DNA with DAPI (<italic>blue</italic>; <bold>d</bold>, <bold>i</bold>, <bold>n</bold>) and observed in differential interference contrast (<italic>DIC</italic>; <bold>e</bold>, <bold>j</bold>, <bold>o</bold>). Merged <italic>red-green</italic> images are shown in <bold>a</bold>, <bold>f</bold>, <bold>k</bold>. Note that initially, binuclear cells (heterokaryons) form, having one bovine and one human nucleus (<bold>a</bold>&#8211;<bold>e</bold>). Occasionally, tri- or multinuclear cells with different admixtures of bovine and human nuclei are also detected. At longer times after mixing, mitotic figures, containing an admixture of bovine and human chromosomes appear (<bold>f</bold>&#8211;<bold>j</bold>) and, eventually, cells with a single nucleus, containing an admixture of the two genomes in mixture (synkaryons) are detected (<bold>k</bold>&#8211;<bold>o</bold>)</p></caption><graphic position="anchor" xlink:href="418_2008_411_Fig2_HTML" id="MO2"/></fig>
###xml 4155 4161 4155 4161 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;3</label>
###xml 4307 4308 4307 4308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 4310 4311 4310 4311 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 4325 4326 4325 4326 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 4461 4467 4461 4467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrows</italic>
###xml 4523 4528 4523 4528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 4553 4556 4553 4556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 4161 4570 4161 4570 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="14">Chromosomal markers and cell fusions. Mixed culture of human breast cancer cells and bovine endothelial cells submitted to double FISH as in Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref> (<bold>a</bold> double FISH; <bold>b</bold> combined DAPI and DIC). Low power micrograph showing a pair of synkaryons with the bovine and human genomes admixed in single nuclei (<italic>arrows</italic>). In addition, nuclei hybridizing only for the bovine (<italic>green</italic>) or only for the human (<italic>red</italic>) genome occur</p>
###xml 4161 4570 4161 4570 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="14">Chromosomal markers and cell fusions. Mixed culture of human breast cancer cells and bovine endothelial cells submitted to double FISH as in Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref> (<bold>a</bold> double FISH; <bold>b</bold> combined DAPI and DIC). Low power micrograph showing a pair of synkaryons with the bovine and human genomes admixed in single nuclei (<italic>arrows</italic>). In addition, nuclei hybridizing only for the bovine (<italic>green</italic>) or only for the human (<italic>red</italic>) genome occur</p></caption>
###xml 4570 4570 4570 4570 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="418_2008_411_Fig3_HTML" id="MO3"/>
###xml 4155 4570 4155 4570 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig3"><label>Fig.&#160;3</label><caption><p textid="14">Chromosomal markers and cell fusions. Mixed culture of human breast cancer cells and bovine endothelial cells submitted to double FISH as in Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref> (<bold>a</bold> double FISH; <bold>b</bold> combined DAPI and DIC). Low power micrograph showing a pair of synkaryons with the bovine and human genomes admixed in single nuclei (<italic>arrows</italic>). In addition, nuclei hybridizing only for the bovine (<italic>green</italic>) or only for the human (<italic>red</italic>) genome occur</p></caption><graphic position="anchor" xlink:href="418_2008_411_Fig3_HTML" id="MO3"/></fig>
###xml 4570 4576 4570 4576 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;4</label>
###xml 4609 4610 4609 4610 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 4612 4614 4612 4614 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b </bold>
###xml 4735 4739 4735 4739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR68">2004</xref>
###xml 4791 4794 4791 4794 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 4818 4823 4818 4823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 4826 4827 4826 4827 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 4867 4868 4867 4868 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 4870 4874 4870 4874 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 4943 4948 4943 4948 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrow</italic>
###xml 5033 5036 5033 5036 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 5184 5188 5184 5188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 5258 5261 5258 5261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 5264 5268 5264 5268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 5290 5291 5290 5291 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 5323 5326 5323 5326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 5378 5383 5378 5383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 5394 5398 5394 5398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 5441 5444 5441 5444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 5447 5451 5447 5451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 5864 5868 5864 5868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR68">2004</xref>
###xml 4576 5869 4576 5869 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="15">Cancer&#8211;host cell fusion in vivo. <bold>a</bold>, <bold>b </bold>Section from lung of a nude mice injected with human breast cancer (MDA-MB-231) cells in the tail vein (Mortensen et al. <xref ref-type="bibr" rid="CR68">2004</xref>). The section underwent FISH for the mouse genome (<italic>red</italic>) and the human genome (<italic>green</italic>) (<bold>a</bold>) and DNA was counterstained with DAPI (<bold>b</bold>; <italic>blue</italic>). Note one nucleus in which the human and mouse genome co-localize (<italic>arrow</italic>). C: Similar section, stained with an antibody detecting human (but not mouse) p53 (<italic>red</italic>; p53 is mutated and overexpressed by the breast cancer cells), an antibody to beta-catenin (to mark cell membranes) and for DNA with bisbenzimide (<italic>blue</italic>). Note a micrometastasis of human breast cancer cells having violet (<italic>red</italic>&#160;+&#160;<italic>blue</italic>) fluorescent nuclei. <bold>d</bold> Section stained for human p53 (<italic>red</italic>) and the endothelial marker von Willebrand factor (<italic>green</italic>) and DNA (<italic>blue</italic>). Note a human cancer cell with a violet (<italic>red</italic>&#160;+&#160;<italic>blue</italic>) nucleus showing membrane-staining for von Willebrand factor. Since von Willebrand factor is not normally expressed by the breast cancer cells, this image is suggestive of a fusion between a human breast cancer cell and a mouse endothelial cell. Similar results were obtained using double FISH for the human and mouse genome and imunofluorescent staining for von Willebrand factor (described by Mortensen et al. <xref ref-type="bibr" rid="CR68">2004</xref>)</p>
###xml 4576 5869 4576 5869 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="15">Cancer&#8211;host cell fusion in vivo. <bold>a</bold>, <bold>b </bold>Section from lung of a nude mice injected with human breast cancer (MDA-MB-231) cells in the tail vein (Mortensen et al. <xref ref-type="bibr" rid="CR68">2004</xref>). The section underwent FISH for the mouse genome (<italic>red</italic>) and the human genome (<italic>green</italic>) (<bold>a</bold>) and DNA was counterstained with DAPI (<bold>b</bold>; <italic>blue</italic>). Note one nucleus in which the human and mouse genome co-localize (<italic>arrow</italic>). C: Similar section, stained with an antibody detecting human (but not mouse) p53 (<italic>red</italic>; p53 is mutated and overexpressed by the breast cancer cells), an antibody to beta-catenin (to mark cell membranes) and for DNA with bisbenzimide (<italic>blue</italic>). Note a micrometastasis of human breast cancer cells having violet (<italic>red</italic>&#160;+&#160;<italic>blue</italic>) fluorescent nuclei. <bold>d</bold> Section stained for human p53 (<italic>red</italic>) and the endothelial marker von Willebrand factor (<italic>green</italic>) and DNA (<italic>blue</italic>). Note a human cancer cell with a violet (<italic>red</italic>&#160;+&#160;<italic>blue</italic>) nucleus showing membrane-staining for von Willebrand factor. Since von Willebrand factor is not normally expressed by the breast cancer cells, this image is suggestive of a fusion between a human breast cancer cell and a mouse endothelial cell. Similar results were obtained using double FISH for the human and mouse genome and imunofluorescent staining for von Willebrand factor (described by Mortensen et al. <xref ref-type="bibr" rid="CR68">2004</xref>)</p></caption>
###xml 5869 5869 5869 5869 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="418_2008_411_Fig4_HTML" id="MO4"/>
###xml 4570 5869 4570 5869 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig4"><label>Fig.&#160;4</label><caption><p textid="15">Cancer&#8211;host cell fusion in vivo. <bold>a</bold>, <bold>b </bold>Section from lung of a nude mice injected with human breast cancer (MDA-MB-231) cells in the tail vein (Mortensen et al. <xref ref-type="bibr" rid="CR68">2004</xref>). The section underwent FISH for the mouse genome (<italic>red</italic>) and the human genome (<italic>green</italic>) (<bold>a</bold>) and DNA was counterstained with DAPI (<bold>b</bold>; <italic>blue</italic>). Note one nucleus in which the human and mouse genome co-localize (<italic>arrow</italic>). C: Similar section, stained with an antibody detecting human (but not mouse) p53 (<italic>red</italic>; p53 is mutated and overexpressed by the breast cancer cells), an antibody to beta-catenin (to mark cell membranes) and for DNA with bisbenzimide (<italic>blue</italic>). Note a micrometastasis of human breast cancer cells having violet (<italic>red</italic>&#160;+&#160;<italic>blue</italic>) fluorescent nuclei. <bold>d</bold> Section stained for human p53 (<italic>red</italic>) and the endothelial marker von Willebrand factor (<italic>green</italic>) and DNA (<italic>blue</italic>). Note a human cancer cell with a violet (<italic>red</italic>&#160;+&#160;<italic>blue</italic>) nucleus showing membrane-staining for von Willebrand factor. Since von Willebrand factor is not normally expressed by the breast cancer cells, this image is suggestive of a fusion between a human breast cancer cell and a mouse endothelial cell. Similar results were obtained using double FISH for the human and mouse genome and imunofluorescent staining for von Willebrand factor (described by Mortensen et al. <xref ref-type="bibr" rid="CR68">2004</xref>)</p></caption><graphic position="anchor" xlink:href="418_2008_411_Fig4_HTML" id="MO4"/></fig>
###xml 649 654 <span type="species:ncbi:9606">human</span>
###xml 1897 1902 <span type="species:ncbi:9606">human</span>
###xml 2220 2228 <span type="species:ncbi:9606">patients</span>
###xml 2664 2672 <span type="species:ncbi:9606">patients</span>
###xml 2877 2882 <span type="species:ncbi:9606">human</span>
###xml 2915 2920 <span type="species:ncbi:9606">human</span>
###xml 3289 3294 <span type="species:ncbi:9606">human</span>
###xml 3319 3325 <span type="species:ncbi:9913">bovine</span>
###xml 3445 3451 <span type="species:ncbi:9913">bovine</span>
###xml 3489 3494 <span type="species:ncbi:9606">human</span>
###xml 3759 3765 <span type="species:ncbi:9913">bovine</span>
###xml 3774 3779 <span type="species:ncbi:9606">human</span>
###xml 3865 3871 <span type="species:ncbi:9913">bovine</span>
###xml 3876 3881 <span type="species:ncbi:9606">human</span>
###xml 3982 3988 <span type="species:ncbi:9913">bovine</span>
###xml 3993 3998 <span type="species:ncbi:9606">human</span>
###xml 4216 4221 <span type="species:ncbi:9606">human</span>
###xml 4246 4252 <span type="species:ncbi:9913">bovine</span>
###xml 4410 4416 <span type="species:ncbi:9913">bovine</span>
###xml 4421 4426 <span type="species:ncbi:9606">human</span>
###xml 4515 4521 <span type="species:ncbi:9913">bovine</span>
###xml 4546 4551 <span type="species:ncbi:9606">human</span>
###xml 4637 4646 <span type="species:ncbi:10090">nude mice</span>
###xml 4661 4666 <span type="species:ncbi:9606">human</span>
###xml 4777 4782 <span type="species:ncbi:10090">mouse</span>
###xml 4804 4809 <span type="species:ncbi:9606">human</span>
###xml 4907 4912 <span type="species:ncbi:9606">human</span>
###xml 4917 4922 <span type="species:ncbi:10090">mouse</span>
###xml 5006 5011 <span type="species:ncbi:9606">human</span>
###xml 5021 5026 <span type="species:ncbi:10090">mouse</span>
###xml 5217 5222 <span type="species:ncbi:9606">human</span>
###xml 5312 5317 <span type="species:ncbi:9606">human</span>
###xml 5408 5413 <span type="species:ncbi:9606">human</span>
###xml 5643 5648 <span type="species:ncbi:9606">human</span>
###xml 5674 5679 <span type="species:ncbi:10090">mouse</span>
###xml 5754 5759 <span type="species:ncbi:9606">human</span>
###xml 5764 5769 <span type="species:ncbi:10090">mouse</span>
In 1911 Aichel suggested that cancer cells might spontaneously fuse with host cells to produce hybrids with supernumerary chromosomes that could evolve into cells of increased malignancy. Subsequent studies have confirmed this prediction by demonstrating that cells with mixed phenotypes spontaneously appear in co-cultures of normal and malignant cells (Barski and Cornefert 1962; Busund et al. 2002; Mortensen et al. 2004; Wakeling et al. 1994) (Figs. 1, 2, 3). Additionally, transplanted tumor cells of animal (Busund et al. 2003; Chakraborty et al. 2000; Fortuna et al. 1990; Kerbel et al. 1983; Larizza et al. 1984a; Wiener et al. 1974a, b) or human (Goldenberg et al. 1974; Goldenberg and Pavia 1982; Mortensen et al. 2004) origin may fuse with and acquire phenotypic characteristics of normal host cells (Fig. 4). In some of the in vivo studies, data suggested that the putative fusion partner was of macrophage or endothelial origin but, in most cases, definite identification was not achieved. In a few cases, it has also been demonstrated that the fused cells expressed genetic markers of both parental cell types (Goldenberg et al. 1974; Mortensen et al. 2004; Wiener et al. 1974a, b) (Figs. 2, 3). Mortensen et al. (2004) demonstrated that, initially after fusion, bi- or multinucleated cells formed and that such cells had the parental genomes seggregated in diffferent nuclei (heterokaryons) (Fig. 2a-e). Subsequently, mitotic figures appeared showing an admixture of the parental chromosomes (Fig. 2f-j). Eventually, cells with the parental genomes mixed in a single nucleus (synkaryons) were detected (Fig. 2k-o). In agreement with the notion that synkaryons appear after mitotic divison of heterokaryons, synkaryons are usually detected in pairs (Fig. 3). A few recent studies present compelling evidence that cells with genetic characteristics of hybrid cells also may appear in human tumors (Andersen et al. 2007; Chakraborty et al. 2004; Yilmaz et al. 2005; Streubel et al. 2004). Thus, in two cases of renal carcinomas, arising in bone marrow transplant recipients, some tumor cells showed genetic markers characterizing the healthy donor (Chakraborty et al. 2004; Yilmaz et al. 2005). Moreover, in patients with multiple myelomas, osteoclasts have been shown to contain an admixture of nuclei, of which some possess tumor-specific chromosomal translocations while others are devoid of translocations (Andersen et al. 2007). Finally, lymphoma-specific genetic abnormalities were described in endothelial cells in B cell lymphomas (Streubel et al. 2004). Although these data do not formally prove that tumor-host cell hybrids did form in these patients, the combined results from studies in vitro and in vivo do present compelling evidence that cell fusions do occur in tumors (reviewed by Pawelek 2005). Fig. 1Cancer-endothelial cell fusion. Co-culture of human breast cancer (MCF-7) cells and human umbilical vein endothelial cells (HUVEC). Cells were stained for the cancer cell marker cytokeratin (red, c), the endothelial cell marker vimentin (green, b) and DNA (bisbenzimide, blue, d). Note in the merged image (a) one fused, multinucleated cell reacting for both cytokeratin and vimentin (orange-yellow)Fig. 2Chromosomal markers and cell fusions. Co-cultures of human breast cancer cells and bovine endothelial cells. The cultures were subjected to fluorescent in situ hybridization (FISH) with probes recognizing all bovine chromosomes (green; b, g, l) and all human chromosomes (red; c, h, m) and counter-stained for DNA with DAPI (blue; d, i, n) and observed in differential interference contrast (DIC; e, j, o). Merged red-green images are shown in a, f, k. Note that initially, binuclear cells (heterokaryons) form, having one bovine and one human nucleus (a-e). Occasionally, tri- or multinuclear cells with different admixtures of bovine and human nuclei are also detected. At longer times after mixing, mitotic figures, containing an admixture of bovine and human chromosomes appear (f-j) and, eventually, cells with a single nucleus, containing an admixture of the two genomes in mixture (synkaryons) are detected (k-o)Fig. 3Chromosomal markers and cell fusions. Mixed culture of human breast cancer cells and bovine endothelial cells submitted to double FISH as in Fig. 2 (a double FISH; b combined DAPI and DIC). Low power micrograph showing a pair of synkaryons with the bovine and human genomes admixed in single nuclei (arrows). In addition, nuclei hybridizing only for the bovine (green) or only for the human (red) genome occurFig. 4Cancer-host cell fusion in vivo. a, b Section from lung of a nude mice injected with human breast cancer (MDA-MB-231) cells in the tail vein (Mortensen et al. 2004). The section underwent FISH for the mouse genome (red) and the human genome (green) (a) and DNA was counterstained with DAPI (b; blue). Note one nucleus in which the human and mouse genome co-localize (arrow). C: Similar section, stained with an antibody detecting human (but not mouse) p53 (red; p53 is mutated and overexpressed by the breast cancer cells), an antibody to beta-catenin (to mark cell membranes) and for DNA with bisbenzimide (blue). Note a micrometastasis of human breast cancer cells having violet (red + blue) fluorescent nuclei. d Section stained for human p53 (red) and the endothelial marker von Willebrand factor (green) and DNA (blue). Note a human cancer cell with a violet (red + blue) nucleus showing membrane-staining for von Willebrand factor. Since von Willebrand factor is not normally expressed by the breast cancer cells, this image is suggestive of a fusion between a human breast cancer cell and a mouse endothelial cell. Similar results were obtained using double FISH for the human and mouse genome and imunofluorescent staining for von Willebrand factor (described by Mortensen et al. 2004)
###end p 11
###begin p 12
###xml 124 129 124 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HUVEC</italic>
###xml 191 194 191 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 196 197 196 197 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 238 243 238 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 245 246 245 246 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 271 275 271 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 277 278 277 278 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 307 308 307 308 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 385 398 385 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">orange-yellow</italic>
###xml 46 51 <span type="species:ncbi:9606">human</span>
###xml 84 89 <span type="species:ncbi:9606">human</span>
Cancer-endothelial cell fusion. Co-culture of human breast cancer (MCF-7) cells and human umbilical vein endothelial cells (HUVEC). Cells were stained for the cancer cell marker cytokeratin (red, c), the endothelial cell marker vimentin (green, b) and DNA (bisbenzimide, blue, d). Note in the merged image (a) one fused, multinucleated cell reacting for both cytokeratin and vimentin (orange-yellow)
###end p 12
###begin p 13
###xml 175 179 175 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FISH</italic>
###xml 229 234 229 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 236 237 236 237 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 239 240 239 240 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 242 243 242 243 <bold xmlns:xlink="http://www.w3.org/1999/xlink">l</bold>
###xml 272 275 272 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 277 278 277 278 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 280 281 280 281 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h</bold>
###xml 283 284 283 284 <bold xmlns:xlink="http://www.w3.org/1999/xlink">m</bold>
###xml 325 329 325 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 331 332 331 332 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 334 335 334 335 <bold xmlns:xlink="http://www.w3.org/1999/xlink">i</bold>
###xml 337 338 337 338 <bold xmlns:xlink="http://www.w3.org/1999/xlink">n</bold>
###xml 392 395 392 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DIC</italic>
###xml 397 398 397 398 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 400 401 400 401 <bold xmlns:xlink="http://www.w3.org/1999/xlink">j</bold>
###xml 403 404 403 404 <bold xmlns:xlink="http://www.w3.org/1999/xlink">o</bold>
###xml 414 423 414 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red-green</italic>
###xml 444 445 444 445 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 447 448 447 448 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 450 451 450 451 <bold xmlns:xlink="http://www.w3.org/1999/xlink">k</bold>
###xml 553 554 553 554 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 555 556 555 556 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 783 784 783 784 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 785 786 785 786 <bold xmlns:xlink="http://www.w3.org/1999/xlink">j</bold>
###xml 915 916 915 916 <bold xmlns:xlink="http://www.w3.org/1999/xlink">k</bold>
###xml 917 918 917 918 <bold xmlns:xlink="http://www.w3.org/1999/xlink">o</bold>
###xml 53 58 <span type="species:ncbi:9606">human</span>
###xml 83 89 <span type="species:ncbi:9913">bovine</span>
###xml 209 215 <span type="species:ncbi:9913">bovine</span>
###xml 253 258 <span type="species:ncbi:9606">human</span>
###xml 523 529 <span type="species:ncbi:9913">bovine</span>
###xml 538 543 <span type="species:ncbi:9606">human</span>
###xml 629 635 <span type="species:ncbi:9913">bovine</span>
###xml 640 645 <span type="species:ncbi:9606">human</span>
###xml 746 752 <span type="species:ncbi:9913">bovine</span>
###xml 757 762 <span type="species:ncbi:9606">human</span>
Chromosomal markers and cell fusions. Co-cultures of human breast cancer cells and bovine endothelial cells. The cultures were subjected to fluorescent in situ hybridization (FISH) with probes recognizing all bovine chromosomes (green; b, g, l) and all human chromosomes (red; c, h, m) and counter-stained for DNA with DAPI (blue; d, i, n) and observed in differential interference contrast (DIC; e, j, o). Merged red-green images are shown in a, f, k. Note that initially, binuclear cells (heterokaryons) form, having one bovine and one human nucleus (a-e). Occasionally, tri- or multinuclear cells with different admixtures of bovine and human nuclei are also detected. At longer times after mixing, mitotic figures, containing an admixture of bovine and human chromosomes appear (f-j) and, eventually, cells with a single nucleus, containing an admixture of the two genomes in mixture (synkaryons) are detected (k-o)
###end p 13
###begin p 14
###xml 146 147 146 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 149 150 149 150 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 164 165 164 165 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 300 306 300 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrows</italic>
###xml 362 367 362 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 392 395 392 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 55 60 <span type="species:ncbi:9606">human</span>
###xml 85 91 <span type="species:ncbi:9913">bovine</span>
###xml 249 255 <span type="species:ncbi:9913">bovine</span>
###xml 260 265 <span type="species:ncbi:9606">human</span>
###xml 354 360 <span type="species:ncbi:9913">bovine</span>
###xml 385 390 <span type="species:ncbi:9606">human</span>
Chromosomal markers and cell fusions. Mixed culture of human breast cancer cells and bovine endothelial cells submitted to double FISH as in Fig. 2 (a double FISH; b combined DAPI and DIC). Low power micrograph showing a pair of synkaryons with the bovine and human genomes admixed in single nuclei (arrows). In addition, nuclei hybridizing only for the bovine (green) or only for the human (red) genome occur
###end p 14
###begin p 15
###xml 33 34 33 34 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 36 38 36 38 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b </bold>
###xml 159 163 159 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR68">2004</xref>
###xml 215 218 215 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 242 247 242 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 250 251 250 251 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 291 292 291 292 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 294 298 294 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 367 372 367 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrow</italic>
###xml 457 460 457 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 608 612 608 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 682 685 682 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 688 692 688 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 714 715 714 715 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 747 750 747 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 802 807 802 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 818 822 818 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 865 868 865 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 871 875 871 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 1288 1292 1288 1292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR68">2004</xref>
###xml 61 70 <span type="species:ncbi:10090">nude mice</span>
###xml 85 90 <span type="species:ncbi:9606">human</span>
###xml 201 206 <span type="species:ncbi:10090">mouse</span>
###xml 228 233 <span type="species:ncbi:9606">human</span>
###xml 331 336 <span type="species:ncbi:9606">human</span>
###xml 341 346 <span type="species:ncbi:10090">mouse</span>
###xml 430 435 <span type="species:ncbi:9606">human</span>
###xml 445 450 <span type="species:ncbi:10090">mouse</span>
###xml 641 646 <span type="species:ncbi:9606">human</span>
###xml 736 741 <span type="species:ncbi:9606">human</span>
###xml 832 837 <span type="species:ncbi:9606">human</span>
###xml 1067 1072 <span type="species:ncbi:9606">human</span>
###xml 1098 1103 <span type="species:ncbi:10090">mouse</span>
###xml 1178 1183 <span type="species:ncbi:9606">human</span>
###xml 1188 1193 <span type="species:ncbi:10090">mouse</span>
Cancer-host cell fusion in vivo. a, b Section from lung of a nude mice injected with human breast cancer (MDA-MB-231) cells in the tail vein (Mortensen et al. 2004). The section underwent FISH for the mouse genome (red) and the human genome (green) (a) and DNA was counterstained with DAPI (b; blue). Note one nucleus in which the human and mouse genome co-localize (arrow). C: Similar section, stained with an antibody detecting human (but not mouse) p53 (red; p53 is mutated and overexpressed by the breast cancer cells), an antibody to beta-catenin (to mark cell membranes) and for DNA with bisbenzimide (blue). Note a micrometastasis of human breast cancer cells having violet (red + blue) fluorescent nuclei. d Section stained for human p53 (red) and the endothelial marker von Willebrand factor (green) and DNA (blue). Note a human cancer cell with a violet (red + blue) nucleus showing membrane-staining for von Willebrand factor. Since von Willebrand factor is not normally expressed by the breast cancer cells, this image is suggestive of a fusion between a human breast cancer cell and a mouse endothelial cell. Similar results were obtained using double FISH for the human and mouse genome and imunofluorescent staining for von Willebrand factor (described by Mortensen et al. 2004)
###end p 15
###begin p 16
###xml 360 364 360 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR40">1969</xref>
###xml 373 377 373 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR41">1988</xref>
###xml 390 394 390 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR79">1976</xref>
###xml 410 415 410 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR88">1974a</xref>
###xml 417 418 417 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR90">b</xref>
###xml 538 542 538 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">1993</xref>
###xml 1225 1229 1225 1229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR54">1975</xref>
###xml 1350 1354 1350 1354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">1962</xref>
###xml 1370 1374 1370 1374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">2003</xref>
###xml 1395 1399 1395 1399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">2001</xref>
###xml 1422 1426 1422 1426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">1981</xref>
###xml 1442 1446 1442 1446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR52">1983</xref>
###xml 1463 1468 1463 1468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR57">1984b</xref>
###xml 1478 1482 1478 1482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR72">2000</xref>
###xml 1502 1506 1502 1506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR74">1998</xref>
###xml 1772 1776 1772 1776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">2007</xref>
###xml 101 108 <span type="species:ncbi:9606">patient</span>
The essential question regarding cancer-host cell fusions is, of course, if they are relevant to the patient. In fact, there are two opposing views. The first is based on early experiments on fusions induced to occur between cancer cells and normal cells in culture. With few exceptions, such experiments revealed that malignancy was suppressed (Harris et al. 1969; Harris 1988; Stanbridge 1976; Wiener et al. 1974a, b). These studies were, in fact, seminal to the discovery of tumor suppressor genes (reviewed by Anderson and Stanbridge 1993). Since tumor suppressor genes, like p53 and Rb, frequently are inactivated in cancer cells, fusions would present cancer cells with unperturbed tumor suppressors from the normal fusion partner and consequently initiate cell cycle arrest or apoptosis. Although, this certainly applied for the cell types studied in the contributions cited above, it may not be a general rule. Thus, production of monoclonal antibodies depends upon the fact that it is possible to fuse antibody-producing spleen cells with myeloma cells to obtain hybridomas that retain the unlimited proliferative ability of the tumor cell partner and the antibody production of the normal cell (Kohler and Milstein 1975). In fact, several studies documented that some fusions may lead to cells of increased malignancy (Barski and Cornefert 1962; Busund et al. 2003; Chakraborty et al. 2001; De Baetselier et al. 1981; Kerbel et al. 1983; Larizza et al. 1984b; Pawelek 2000; Rachkovsky et al. 1998). Possibly, the genetic make-up of tumors may dictate the outcome of individual cancer-host cell fusions. Moreover, fusions lead to aneuploidy and chromosomal instability, which characterizes most cancers and may, by itself, stimulate carcinogenesis (Duelli et al. 2007).
###end p 16
###begin title 17
Mechanisms behind cell-cell fusions
###end title 17
###begin title 18
Fusions between normal cells
###end title 18
###begin p 19
###xml 742 746 742 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR91">1998</xref>
###xml 1032 1036 1032 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">2003</xref>
###xml 1050 1054 1050 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR49">2003</xref>
###xml 1526 1530 1526 1530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">2000</xref>
###xml 1542 1546 1542 1546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR65">2000</xref>
###xml 2227 2231 2227 2231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">2004</xref>
###xml 2245 2249 2245 2249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR39">2005</xref>
###xml 2394 2398 2394 2398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">2004</xref>
###xml 2473 2477 2473 2477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">2000</xref>
###xml 2583 2587 2583 2587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR60">2000</xref>
###xml 2786 2790 2786 2790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">2000</xref>
###xml 2805 2809 2805 2809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">2004</xref>
###xml 2821 2825 2821 2825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR65">2000</xref>
###xml 2963 2967 2963 2967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR53">1998</xref>
###xml 3093 3097 3093 3097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">2003</xref>
###xml 3165 3169 3165 3169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">2003</xref>
###xml 3346 3350 3346 3350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR95">2002</xref>
###xml 3482 3486 3482 3486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">2006</xref>
###xml 3586 3590 3586 3590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR55">2003</xref>
###xml 1705 1710 <span type="species:ncbi:9606">human</span>
Cell fusion events must be extremely well controlled. Due to their major importance to fertilization, placentation, muscle development, bone structure, calcium homeostasis and the immune defense system, much effort has gone into elucidating mechanisms underlying cell-cell fusions. Additionally, the potential role of cell fusions as a repair mechanism and the role of cell fusions in cancer development and progression have further stimulated research in this field. In spite of this, much less is known about cell-cell fusion mechanisms than is known about how intracellular membranes fuse through v- and t-SNAREs. Interestingly, engineered flipping of the v- and t-SNARE machinery has been shown to promote cell-cell fusions (Weber et al. 1998). However, it is evident that this mechanism is not a physiological mediator of cell-cell fusions. Interestingly, v- and t-SNAREs act similar to class I viral fusion proteins in that they form bundles of alpha-helices, which result in membrane apposition and fusion (Blumenthal et al. 2003; Jahn et al. 2003). Of the many proteins, which to date have been shown (or proposed) to be involved in cell fusions in mammals, only the syncytin family appears to use a similar alpha-helical mechanism. That they do is not surprising in view of the fact that syncytins represent conserved endogenous retroviral Env sequences. The founding family member, syncytin-1, was discovered as a protein capable of mediating fusions between cytotrophoblasts into syncytiotrophoblasts (Blond et al. 2000; Mi et al. 2000). This capability may have contributed to a high degree of evolutionary conservation of the syncytin-1 sequence. Syncytin-1 represents the Env protein of the human endogenous retroviral (HERV) W sequence, which entered the primate genome 25-40 million years ago. In contrast, most other retroviral sequences inserted in our genome have been subject to inactivating changes and probably represent garbage sequences. Molecular studies have shown that syncytin-1 (Env W) shares a structure similar to class I viral fusion proteins, especially in the region of the N- and C-terminal heptad repeats (NHR and CHR), and shares a common fusion mechanism with these proteins (Chang et al. 2004; Gong et al. 2005). A synthetic peptide derived from the CHR is also capable of inhibiting syncytin-1-mediated fusions by perturbing this mechanism (Chang et al. 2004). Syncytin-1 binds to the D-type retroviral receptor ASCT-2 (Blond et al. 2000) and may use another neutral amino acid transporter (ASCT-1) as an auxiliary receptor (Lavillette et al. 2000). Syncytin antibodies, syncytin-1 downregulation through antisense oligonucleotides and the syncytin-1 CHR peptide have been shown to inhibit fusions between trophoblast-derived cells (Blond et al. 2000; Chang et al. 2004; Mi et al. 2000). Agents increasing cellular levels of cAMP or cAMP analogues have been shown to promote cytotrophoblast fusions in vitro (Keryer et al. 1998) and such agents are also known to elevate protein and mRNA levels of syncytin-1 in isolated cytotrophoblasts (Frendo et al. 2003). Also estradiol may regulate syncytin-1 expression (Carino et al. 2003) and the placenta-specific transcription factor GCMa interacts with two upstream sites in the HERV-W 5'-long terminal repeat and stimulates syncytin-1 transcription (Yu et al. 2002). Additionally, experimentally induced truncations in the cytoplasmic tail of syncytin-1 increases its fusogenicity (Drewlo et al. 2006), similar to what has been observed for some virally derived Env proteins (reviewed by Kubo et al. 2003). However, if modifications in the cytoplasmic tail of syncytin-1 are of physiological importance for regulating fusogenicity has yet to be demonstrated.
###end p 19
###begin p 20
###xml 120 124 120 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">2003</xref>
###xml 266 270 266 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">2003</xref>
###xml 397 398 397 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 754 758 754 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR63">2008</xref>
###xml 859 863 859 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR43">2007</xref>
###xml 1067 1073 1067 1073 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;5</label>
###xml 1073 1288 1073 1288 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="21">Human term placenta immunocytochemically stained with a syncytin-1 peptide antiserum. Staining occurs in the syncytiotrophoblasts, which predominate at this stage. Nuclei are lightly counterstained with haematoxylin</p>
###xml 1073 1288 1073 1288 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="21">Human term placenta immunocytochemically stained with a syncytin-1 peptide antiserum. Staining occurs in the syncytiotrophoblasts, which predominate at this stage. Nuclei are lightly counterstained with haematoxylin</p></caption>
###xml 1288 1288 1288 1288 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="418_2008_411_Fig5_HTML" id="MO5"/>
###xml 1067 1288 1067 1288 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig5"><label>Fig.&#160;5</label><caption><p textid="21">Human term placenta immunocytochemically stained with a syncytin-1 peptide antiserum. Staining occurs in the syncytiotrophoblasts, which predominate at this stage. Nuclei are lightly counterstained with haematoxylin</p></caption><graphic position="anchor" xlink:href="418_2008_411_Fig5_HTML" id="MO5"/></fig>
A second syncytin-family member, syncytin-2, was subsequently found also to be expressed in the placenta (Blaise et al. 2003). Syncytin-2 also represents a highly conserved endogenous retroviral envelope gene and is derived from the HERV FRD sequence (Blaise et al. 2003). Immunocytochemical studies have localized syncytin-1 primarily to syncytiotrophoblasts as well as to cytotrophoblasts (Fig. 5). The exact localization is somewhat controversial (reviewed by Potgens et al. 2004), which may reflect differences in antibodies, fixation procedures and controls. A major point of concern is also the degree of cross-reactivity to the related sequences in syncytin-2, which recently was localized to a subpopulation of cytotrophoblasts (Malassine et al. 2008). The syncytin-1 receptor protein ASCT-2 was recently localized to cytotrophoblasts (Hayward et al. 2007). More studies on the exact distribution of syncytin expression in the placenta using syncytin-1 and -2 specific antibodies seem warranted in order to exactly localize where fusions are likely to occur. Fig. 5Human term placenta immunocytochemically stained with a syncytin-1 peptide antiserum. Staining occurs in the syncytiotrophoblasts, which predominate at this stage. Nuclei are lightly counterstained with haematoxylin
###end p 20
###begin p 21
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human term placenta immunocytochemically stained with a syncytin-1 peptide antiserum. Staining occurs in the syncytiotrophoblasts, which predominate at this stage. Nuclei are lightly counterstained with haematoxylin
###end p 21
###begin p 22
###xml 383 387 383 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">2005</xref>
###xml 618 622 618 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">2005</xref>
###xml 777 781 777 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR38">2007</xref>
###xml 1284 1288 1284 1288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR64">2007</xref>
###xml 1378 1382 1378 1382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">2000</xref>
###xml 1394 1398 1394 1398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR65">2000</xref>
###xml 1497 1501 1497 1501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">2004</xref>
###xml 1568 1572 1568 1572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">2006</xref>
###xml 1588 1592 1588 1592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR81">2007</xref>
###xml 1744 1748 1744 1748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">2004</xref>
###xml 93 98 <span type="species:ncbi:10090">mouse</span>
###xml 160 164 <span type="species:ncbi:10090">mice</span>
###xml 246 251 <span type="species:ncbi:10090">mouse</span>
###xml 290 296 <span type="species:ncbi:10090">murine</span>
###xml 491 495 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
###xml 759 763 <span type="species:ncbi:10090">mice</span>
Trophoblast cell fusions are, however, not unique to the primate placenta. Thus, also in the mouse placenta, trophoblasts fuse to form syncytiotrophoblasts but mice do, of course, not express HERV sequences. Amazingly, an in-silico search of the mouse genome unraveled the existence of two murine endogenous retroviral (MERV) Env genes, labeled syncytin-A and -B (Dupresssoir et al. 2005). These genes were also fusogenic and orthologous genes were present in additional species of muridae (rats, gerbils, voles and hamsters) and appear to have entered the rodent lineage some 20 million years ago (Dupresssoir et al. 2005). They were expressed in the placenta and at least syncytin-A has been shown to be involved in the formation of syncytiotrophoblasts in mice (Gong et al. 2007). This represents an amazing example of parallel acquisition of retroviral genes of importance to reproduction in primates and rodents and poses the question whether also other species may have acquired similar viral genes of importance to cell fusions. The ability of syncytins to induce cell fusions may not be their only physiologic role. Thus, recent studies have shown that while syncytin-2 and syncytin-B also possess immunosuppressive activity, syncytin-1 and syncytin-A do not (Mangeney et al. 2007). Syncytin-1 expression was originally detected in the placenta and testis (Blond et al. 2000; Mi et al. 2000) but subsequent studies have revealed the presence of syncytin-1 also in the brain (Antony et al. 2004) and in breast, colon and endometrial cancers (Bjerregaard et al. 2006; Strick et al. 2007, Larsen, Talts, Andersen, Bjerregaard and Larsson: work in progress). Syncytin-1 may also regulate production of inflammatory mediators (Antony et al. 2004).
###end p 22
###begin p 23
###xml 223 227 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">2005</xref>
###xml 241 245 241 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">2007</xref>
###xml 275 279 275 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR70">2007</xref>
###xml 516 520 516 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1999</xref>
###xml 538 542 538 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR34">2000</xref>
###xml 558 562 558 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR35">1998</xref>
###xml 587 591 587 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR92">1995</xref>
###xml 792 796 792 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">2005</xref>
###xml 809 813 809 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">1997</xref>
###xml 815 819 815 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">1998</xref>
###xml 834 838 834 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">1998</xref>
###xml 852 856 852 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR50">1997</xref>
###xml 858 862 858 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR51">1998</xref>
###xml 958 962 958 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR61">2000</xref>
###xml 1147 1151 1147 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR46">1999</xref>
###xml 1164 1168 1164 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR62">2006</xref>
###xml 1317 1321 1317 1321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR82">1999</xref>
###xml 1472 1476 1472 1476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">2005</xref>
###xml 1665 1669 1665 1669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR44">2003</xref>
###xml 1690 1694 1690 1694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR78">2006</xref>
###xml 1838 1842 1838 1842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR96">2006</xref>
###xml 2177 2181 2177 2181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR76">1995</xref>
###xml 2183 2187 2183 2187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR77">1998</xref>
###xml 2209 2213 2209 2213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR84">2005</xref>
###xml 2414 2418 2414 2418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">2007</xref>
###xml 2826 2830 2826 2830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR86">2005</xref>
###xml 2948 2952 2948 2952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">2007</xref>
###xml 3360 3364 3360 3364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR93">2005</xref>
###xml 134 139 <span type="species:ncbi:4932">yeast</span>
###xml 143 146 <span type="species:ncbi:9606">man</span>
###xml 730 733 <span type="species:ncbi:9606">man</span>
###xml 1106 1111 <span type="species:ncbi:10090">mouse</span>
###xml 1411 1436 <span type="species:ncbi:11855">Mason-Pfizer monkey virus</span>
###xml 2120 2123 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 3255 3259 <span type="species:ncbi:10090">Mice</span>
###xml 3435 3438 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
A number of additional molecules have been shown to be important to cell fusions. In fact, in all systems studied so far, from mating yeast to man, a bewildering array of mechanisms have been identified (see Chen and Olson 2005; Chen et al. 2007; Oren-Suissa and Podbilewicz 2007 for recent reviews). Molecules potentially involved in mammalian cell fusions include ADAM (a disintegrin and metalloproteinase domain) 12 (meltrin alpha), which has been associated with myoblast and osteoclast cell fusions (Abe et al. 1999; Galliano et al. 2000; Gilpin et al. 1998; Yagami-Hiromasa et al. 1995). In addition, ADAMs 1 and 2 (fertilins) may be involved in sperm-oocyte fusions, but do not seem indispensable for this function and, in man, the fertilin alpha gene is dysfunctional (Chen and Olson 2005; Cho et al. 1997, 1998, Evans et al. 1998; Jury et al. 1997, 1998). In contrast, the tetraspanin protein CD9 is needed for sperm-oocyte fusions (Le Naour et al. 2000). CD9 is also expressed by BeWo trophoblast tumor (choriocarcinoma) cells and has been linked both to BeWo invasiveness and to invasion during mouse embryo implantation (Hirano et al. 1999; Liu et al. 2006). CD9 has, together with another tetraspanin family member, CD81, also been linked to myoblast fusion and myotube maintenance (Tachibana and Hemler 1999). Moreover, antibodies to either CD9 or CD81 have been shown to block fusions induced by Mason-Pfizer monkey virus-a D-type retrovirus (Duelli et al. 2005). Tetraspanins are known to organize other proteins into membrane microdomains and may link to the actin cytoskeleton via EWI (Glu-Trp-Ile) and ERM (ezrin-radixin-moesin) proteins (Hemler 2003; Sala-Valdes et al. 2006). Possibly, their role as organizers of other proteins into microdomains may play a role in their involvement with cell fusions (Zivyat et al. 2006). They do not express characteristics of fusogenic proteins like the syncytins, SNAREs and class I viral envelope proteins, but are coexpressed with syncytin-1, at least in BeWo cells. A macrophage fusion receptor (MFR, SIRPalpha), resembling CD4-the cell surface receptor for HIV-has been identified in macrophages (Saginario et al. 1995, 1998; van den Berg et al. 2005). MFR, which belongs to the immunoglobulin superfamily, binds another member of this family, CD47. CD47 is also structurally related to proteins expressed by Vaccinia and Variola viruses (Chen et al. 2007). Whereas expression of MFR is restricted to myeloid cells and neurons, CD47 is ubiquitously expressed. MFR is transiently induced in macrophages at the onset of fusion while CD47 expression is constant. It has been hypothesized that CD47 initially binds to a long form of MFR to secure recognition and then switches to bind a shorter form to bring the plasma membranes closer (5-10 nm) for fusion (Vignery 2005). Additionally, or alternatively, CD47 may promote calcium entry by forming a membrane pore (reviewed in Chen et al. 2007). Also the hyaluronan receptor, CD44, is induced transiently when macrophages start to fuse. CD44 and MFR are subsequently cleaved by proteases during fusion. As mentioned above, CD9 and CD81 may also contribute to macrophage fusion. Additionally, DC-STAMP seems to be required for macrophage fusions. Mice lacking DC-STAMP are osteopetrotic and lack multinucleated osteoclasts and giant cells (Yagi et al. 2005). DC-STAMP is a seven-transmembrane receptor, somewhat similar to the HIV co-receptor CXCR4, but a ligand has yet to be identified.
###end p 23
###begin p 24
###xml 382 386 382 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">2005</xref>
###xml 400 404 400 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">2007</xref>
###xml 434 438 434 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR70">2007</xref>
###xml 600 603 <span type="species:ncbi:9606">man</span>
###xml 608 613 <span type="species:ncbi:10090">mouse</span>
These and many more molecules, including integrins, vacuolar ATPase and receptors and their ligands, as well as different signaling intermediates have been associated with cell fusions. With the exception of the syncytins, most of the mammalian molecules so far studied do not fulfill strict criteria for fusogens and several are dispensable for fusions (reviewed by Chen and Olson 2005; Chen et al. 2007; Oren-Suissa and Podbilewicz 2007). However, this may reflect molecular redundancy and does not definitely exclude that these molecules may participate in fusions. It is noteworthy that, in both man and mouse, two different syncytins are expressed and are both fusogenic. It is possible that, in the mammalian system, fusion requires a flotilla of molecules organized into membrane microdomains by proteins like CD9, encompassing receptors/ligands, signaling entities, proteases and fusogens of retroviral origin that are capable of forming alpha-helical bundles, which bring membranes closer. Syncytins and related retroviral envelope sequences may, in this connection, function both as fusogens and receptor ligands. However, it seems unlikely that as irreversible an event as a cell-cell fusion should depend upon a single receptor-ligand interaction. Thus, both facilitatory and inhibitory factors are expected to be part of the flotilla.
###end p 24
###begin title 25
Cancer cell fusions
###end title 25
###begin p 26
###xml 29 33 29 33 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR68">2004</xref>
###xml 223 227 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">2000</xref>
###xml 239 243 239 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR65">2000</xref>
###xml 466 470 466 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">2006</xref>
###xml 1083 1087 1083 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">2006</xref>
###xml 51 56 <span type="species:ncbi:9606">human</span>
Studies by Mortensen et al. (2004) documented that human breast cancer cells fused with endothelial cells in culture. Stimulated by studies showing that syncytin-1 was involved in cytotrophoblast cell fusions (Blond et al. 2000; Mi et al. 2000), we examined whether a similar mechanism could account for cancer-endothelial cell fusions. Expression of syncytin-1 was documented in the breast cancer cell lines examined (MCF-7 and MDA-MB-231 cells; Bjerregaard et al. 2006, SK-BR-3 cells: Talts, Bjerregaard and Larsson: unpublished data). Moreover, we found that both tumor cells and endothelial cells expressed the syncytin-1 receptor ASCT-2. Use of phosphorthioate-protected syncytin-1 antisense oligonucleotides downmodulated syncytin-1 expression as measured by either quantitative RT-PCR or Western blotting and inhibited breast cancer-endothelial cell fusions, whereas a scrambled oligonucleotide control was without effect. Additionally, the syncytin-1 CHR peptide, referred to above, also inhibited the fusions whereas a control peptide was without effect (Bjerregaard et al. 2006). However, neither the antisense nor the CHR peptide experiments effected a total inhibition of cancer-endothelial cell fusions. There may be several reasons to this. Thus, the antisense oligonucleotide did not totally downmodulate syncytin-1 levels and could therefore not be expected to decrease cell fusions to zero and the lack of total inhibition by the CHR peptide could potentially be ascribed to proteolytic degradation. However, we also detected that the breast cancer cells produced syncytin-2 and cannot exclude that also this molecule contributed to the cancer-host cell fusions. Further experiments using shRNA-directed downmodulation of both syncytin-1 and -2 as well as of additional putative fusogenic retroviral sequence are now underway to test this. Nevertheless, these data provide strong evidence that syncytin-1 is involved in mediating cancer-endothelial cell fusions in vitro.
###end p 26
###begin p 27
###xml 421 426 421 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR59">2007b</xref>
###xml 434 435 434 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6</xref>
###xml 585 586 585 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6</xref>
###xml 676 677 676 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6</xref>
###xml 881 886 881 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR59">2007b</xref>
###xml 1271 1272 1271 1272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1297 1302 1297 1302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR59">2007b</xref>
###xml 1305 1311 1305 1311 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;6</label>
###xml 1377 1378 1377 1378 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1419 1420 1419 1420 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1438 1439 1438 1439 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1441 1442 1441 1442 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 1483 1484 1483 1484 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1651 1657 1651 1657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrows</italic>
###xml 1311 1677 1311 1677 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="28">Human breast cancers immunocytochemically stained for syncytin-1 (<bold>a</bold>) or with antigen-preabsorbed antiserum (<bold>b</bold>) and for ASCT-2 (<bold>c</bold>, <bold>e</bold>) or with antigen-preabsorbed antiserum (<bold>d</bold>). Nuclei are lightly counterstained with haematoxylin. Note presence of syncytin immunoreactivity in tumor cells and of ASCT-2 immunoreactivity in endothelial cells (<italic>arrows</italic>) and in tumor cells</p>
###xml 1311 1677 1311 1677 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="28">Human breast cancers immunocytochemically stained for syncytin-1 (<bold>a</bold>) or with antigen-preabsorbed antiserum (<bold>b</bold>) and for ASCT-2 (<bold>c</bold>, <bold>e</bold>) or with antigen-preabsorbed antiserum (<bold>d</bold>). Nuclei are lightly counterstained with haematoxylin. Note presence of syncytin immunoreactivity in tumor cells and of ASCT-2 immunoreactivity in endothelial cells (<italic>arrows</italic>) and in tumor cells</p></caption>
###xml 1677 1677 1677 1677 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="418_2008_411_Fig6_HTML" id="MO6"/>
###xml 1305 1677 1305 1677 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig6"><label>Fig.&#160;6</label><caption><p textid="28">Human breast cancers immunocytochemically stained for syncytin-1 (<bold>a</bold>) or with antigen-preabsorbed antiserum (<bold>b</bold>) and for ASCT-2 (<bold>c</bold>, <bold>e</bold>) or with antigen-preabsorbed antiserum (<bold>d</bold>). Nuclei are lightly counterstained with haematoxylin. Note presence of syncytin immunoreactivity in tumor cells and of ASCT-2 immunoreactivity in endothelial cells (<italic>arrows</italic>) and in tumor cells</p></caption><graphic position="anchor" xlink:href="418_2008_411_Fig6_HTML" id="MO6"/></fig>
###xml 31 36 <span type="species:ncbi:9606">human</span>
###xml 51 59 <span type="species:ncbi:9606">patients</span>
###xml 856 864 <span type="species:ncbi:9606">patients</span>
We next examined two series of human breast cancer patients for tumoral expression of syncytin-1 using a polyclonal antiserum raised to a synthetic nonapeptide derived from the syncytin-1 sequence. In addition, tumors were also screened for expression of ASCT-2 using a peptide antiserum. Preabsorption of the antisera with the corresponding peptides, but not with irrelevant peptides, abolished staining (Larsson et al. 2007b) (Fig. 6). The results showed that 38% of all breast cancer samples showed detectable staining for syncytin and that endothelial cells expressed ASCT-2 (Fig. 6). Moreover, significant expression of ASCT-2 was detected also in many tumor cells (Fig. 6). The degree of syncytin immunostaining was visually graded using coded specimens and statistical analysis showed that it correlated positively with disease-free survival of the patients (Larsson et al. 2007b). Multivariate analysis included age dichotomized at 40 years, tumor size dichotomized at 20 mm, grade and adjuvant therapy and identified syncytin expression as an independent prognostic indicator of increased disease-free survival Also when used as a continuous variable, syncytin expression emerged as a significant prognostic indicator for disease-free survival in the Cox model (P = 0.02) (Larsson et al. 2007b). Fig. 6Human breast cancers immunocytochemically stained for syncytin-1 (a) or with antigen-preabsorbed antiserum (b) and for ASCT-2 (c, e) or with antigen-preabsorbed antiserum (d). Nuclei are lightly counterstained with haematoxylin. Note presence of syncytin immunoreactivity in tumor cells and of ASCT-2 immunoreactivity in endothelial cells (arrows) and in tumor cells
###end p 27
###begin p 28
###xml 66 67 66 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 108 109 108 109 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 127 128 127 128 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 130 131 130 131 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 172 173 172 173 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 340 346 340 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrows</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human breast cancers immunocytochemically stained for syncytin-1 (a) or with antigen-preabsorbed antiserum (b) and for ASCT-2 (c, e) or with antigen-preabsorbed antiserum (d). Nuclei are lightly counterstained with haematoxylin. Note presence of syncytin immunoreactivity in tumor cells and of ASCT-2 immunoreactivity in endothelial cells (arrows) and in tumor cells
###end p 28
###begin p 29
###xml 103 107 103 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR81">2007</xref>
###xml 471 475 471 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR81">2007</xref>
###xml 1155 1159 1155 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR81">2007</xref>
The involvement of syncytin-1 in tumor cell fusion events was subsequently confirmed by Strick et al. (2007), working with endometrial carcinomas. In their study, downmodulation of synctytin-1 expression also inhibited fusions between endometrial tumor cells. In agreement with findings on placental cells (vide supra), both cAMP elevating agents and estrogens upregulated syncytin-1 expression. However, only cAMP elevating agents stimulated cell fusions (Strick et al. 2007). This apparent discrepancy may possibly be ascribed to the fact that estrogen treatment upregulated TGFbeta, which interfered with syncytin-induced fusions. Thus, estrogen did, in fact, stimulate cell fusions if TGFbeta was immunoneutralized. Conversely, additions of TGFbeta 1 or 3 reduced fusions induced by cAMP-elevating agents. This effect was observed both in endometrial carcinoma cells and in trophoblast-derived cells. These results show that both cAMP and estrogens positively may regulate syncytin-1 expression in tumor cells and that the TGFbeta family may negatively regulate the fusogenic effects of syncytin-1 in both trophoblasts and cancer cells (Strick et al. 2007).
###end p 29
###begin p 30
###xml 218 222 218 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR81">2007</xref>
###xml 617 622 617 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR58">2007a</xref>
###xml 624 625 624 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR59">b</xref>
###xml 1139 1143 1139 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">2003</xref>
###xml 1160 1164 1160 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR42">2002</xref>
###xml 1185 1189 1185 1189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR45">1997</xref>
###xml 1204 1208 1204 1208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR48">2002</xref>
###xml 1224 1228 1224 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR66">1995</xref>
###xml 1244 1248 1244 1248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR83">1999</xref>
The role of syncytin-1 and cell fusions in cancer needs further study. Thus, our data show that syncytin-1 is not the only fusogenic protein expressed by breast cancer cells and the results presented by Strick et al. (2007) show that additional regulators, such as TGFbeta isoforms may be important modulators of cell fusions. So far, our breast cancer data indicate that syncytin-1 expression constitutes a positive prognostic factor. This is not the same as to say that cell fusions may be universally beneficial to cancers. First, syncytins may have additional effects within the tumor environment (Larsson et al. 2007a, b). Secondly, it seems likely that several factors within the cancer and its stroma (inactivated tumor suppressor genes, activated oncogenes, expression of fusogens and of CD9 and CD81 as well as TGFbeta) may act together to bring about a tumor profile that may be as diverse as the one demonstrated by the cell fusion experiments referred to above. Interestingly, however, expression of CD9 has been analyzed in a number of tumors and seems, like syncytin expression, to predict a good prognosis (Funakoshi et al. 2003; Hashida et al. 2002; Higashiyama et al. 1997; Houle et al. 2002; Miyake et al. 1995; Uchida et al. 1999). We propose that syncytins may be fusogens of importance to both trophoblast and cancer cell fusions and that they possibly also may mediate additional cell fusion events, acting in concert with other molecules with both enhancing and inhibitory regulatory effects.
###end p 30
###begin p 31
Work by the authors reported herein was supported by the Lundbeck Foundation, the Danish Medical Research Council and the Danish Cancer Society.
###end p 31
###begin title 32
References
###end title 32
###begin article-title 33
Meltrin-alpha, a fusion protein involved in multinucleated giant cell and osteoclast formation
###end article-title 33
###begin article-title 34
Uber Zellverschmelzung mit qualitative abnormer chromosomenverteilung
###end article-title 34
###begin article-title 35
Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes
###end article-title 35
###begin article-title 36
###xml 29 37 <span type="species:ncbi:9606">patients</span>
Osteoclast nuclei of myeloma patients show chromosome translocations specific for the myeloma cell clone: a new type of cancer-host partnership?
###end article-title 36
###begin article-title 37
Tumor suppressor genes studied by cell hybridization and chromosome transfer
###end article-title 37
###begin article-title 38
###xml 0 27 <span type="species:ncbi:11827">Human endogenous retrovirus</span>
Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination
###end article-title 38
###begin article-title 39
Characteristics of "hybrid"-type clonal cell lines obtained from mixed cultures in vitro
###end article-title 39
###begin article-title 40
The satellite cell and muscle regeneration
###end article-title 40
###begin article-title 41
Syncytin is involved in breast cancer-endothelial cell fusions
###end article-title 41
###begin article-title 42
###xml 35 62 <span type="species:ncbi:11827">human endogenous retrovirus</span>
Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution
###end article-title 42
###begin article-title 43
###xml 32 59 <span type="species:ncbi:11827">human endogenous retrovirus</span>
###xml 87 92 <span type="species:ncbi:9606">human</span>
An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor
###end article-title 43
###begin article-title 44
Membrane fusion
###end article-title 44
###begin article-title 45
Spontaneous hybridization of macrophages and Meth A sarcoma cells
###end article-title 45
###begin article-title 46
Spontaneously formed tumorigenic hybrids of Meth A sarcoma cells and macrophages in vivo
###end article-title 46
###begin article-title 47
Estradiol stimulation increases syncytin expression in normal trophoblasts in vitro
###end article-title 47
###begin article-title 48
Donor DNA in a renal cell carcinoma metastasis from a bone marrow transplant recipient
###end article-title 48
###begin article-title 49
###xml 62 63 62 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
Fusion hybrids with macrophage and melanoma cells up-regulate N-acetylglucosaminyltransferase V, beta1-6 branching, and metastasis
###end article-title 49
###begin article-title 50
###xml 14 20 <span type="species:ncbi:10090">murine</span>
A spontaneous murine melanoma lung metastasis comprised of host x tumor hybrids
###end article-title 50
###begin article-title 51
Functional characterization of the placental fusogenic membrane protein syncytin
###end article-title 51
###begin article-title 52
Cell-cell fusion
###end article-title 52
###begin article-title 53
Unveiling the mechanisms of cell-cell fusion
###end article-title 53
###begin article-title 54
###xml 28 33 <span type="species:ncbi:10090">mouse</span>
Genomic organization of the mouse fertilin beta gene that encodes an ADAM family protein active in sperm-egg fusion
###end article-title 54
###begin article-title 55
###xml 36 40 <span type="species:ncbi:10090">mice</span>
Fertilization defects in sperm from mice lacking fertilin beta
###end article-title 55
###begin article-title 56
Metastatic properties conferred on nonmetastatic tumors by hybridization of spleen B-lymphocytes with plasmacytoma cells
###end article-title 56
###begin article-title 57
Apoptotic conversion: evidence for exchange of genetic information between prostate cancer cells mediated by apoptosis
###end article-title 57
###begin article-title 58
C-terminal truncations of syncytin-1 (ERVWE1 envelope) that increase its fusogenicity
###end article-title 58
###begin article-title 59
###xml 38 43 <span type="species:ncbi:9606">human</span>
A primate virus generates transformed human cells by fusion
###end article-title 59
###begin article-title 60
A virus causes cancer by inducing massive chromosoma instability through cell fusion
###end article-title 60
###begin article-title 61
###xml 59 65 <span type="species:ncbi:10090">murine</span>
Syncytin-A and syncytin-B, two fusogenic placenta-specific murine envelope gtenes of retroviral origin conserved in Muridae
###end article-title 61
###begin article-title 62
###xml 36 41 <span type="species:ncbi:10090">mouse</span>
Roles of the disintegrin domains of mouse fertilins alpha and beta in fertilization
###end article-title 62
###begin article-title 63
Enhanced lung colonization and tumorigenicity of fused cells isolated from primary MCA tumors
###end article-title 63
###begin article-title 64
###xml 49 54 <span type="species:ncbi:9606">human</span>
Direct involvement of HERV-W Env glycoprotein in human trophoblast cell fusion and differentiation
###end article-title 64
###begin article-title 65
###xml 30 35 <span type="species:ncbi:9606">human</span>
Expression of tetraspanins in human lung cancer cells: frequent downregulation of CD9 and its contribution to cell motility in small cell lung cancer
###end article-title 65
###begin article-title 66
Binding of ADAM12, a marker of skeletal muscle regeneration, to the muscle-specific actin-binding protein, alpha-actinin-2, is required for myoblast fusion
###end article-title 66
###begin article-title 67
###xml 25 30 <span type="species:ncbi:9606">human</span>
A novel secreted form of human ADAM 12 (meltrin alpha) provokes myogenesis in vivo
###end article-title 67
###begin article-title 68
###xml 36 41 <span type="species:ncbi:9606">human</span>
###xml 51 60 <span type="species:ncbi:10090">nude mice</span>
In vivo horizontal oncogenesis by a human tumor in nude mice
###end article-title 68
###begin article-title 69
###xml 25 30 <span type="species:ncbi:9606">human</span>
In vivo hybridisation of human tumour and normal hamster cells
###end article-title 69
###begin article-title 70
###xml 69 74 <span type="species:ncbi:10090">mouse</span>
Syncytin-A mediates the formation of syncytiotrophoblast involved in mouse placental development
###end article-title 70
###begin article-title 71
###xml 80 107 <span type="species:ncbi:11827">human endogenous retrovirus</span>
Structural characterization of the fusion core in syncytin, envelope protein of human endogenous retrovirus family W
###end article-title 71
###begin article-title 72
Suppression of malignancy by cell fusion
###end article-title 72
###begin article-title 73
The analysis of malignancy by cell fusion: the position in 1988
###end article-title 73
###begin article-title 74
Integrin alpha3 expression as a prognostic factor in colon cancer: association with MRP-1/CD9 and KAI1/CD82
###end article-title 74
###begin article-title 75
###xml 16 43 <span type="species:ncbi:11827">human endogenous retrovirus</span>
###xml 70 75 <span type="species:ncbi:9606">human</span>
Distribution of human endogenous retrovirus type W receptor in normal human villous placenta
###end article-title 75
###begin article-title 76
Tetraspanin proteins mediate cellular penetration, invasion and fusion events and define a novel type of membrane microdomain
###end article-title 76
###begin article-title 77
Immunohistochemically detected expression of motility-related protein-1 (MRP-1/CD9) in lung adenocarcinoma, its relation to prognosis
###end article-title 77
###begin article-title 78
###xml 31 36 <span type="species:ncbi:9606">human</span>
CD9 is involved in invasion of human trophoblast-like choriocarcinoma cell line, BeWo cells
###end article-title 78
###begin article-title 79
Horizontal transfer of DNA by the uptake of apoptotic bodies
###end article-title 79
###begin article-title 80
Loss of expression and altered localization of KAI1 and CD9 protein are associated with epithelial ovarian cancer progression
###end article-title 80
###begin article-title 81
Membrane fusion
###end article-title 81
###begin article-title 82
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human fertilin alpha gene is non-functional: implications for its proposed role in fertilization
###end article-title 82
###begin article-title 83
###xml 105 112 <span type="species:ncbi:499232|species:ncbi:9593">gorilla</span>
###xml 117 120 <span type="species:ncbi:9606">man</span>
Sequence analysis of a variety of primate fertilin alpha genes: evidence for non-functional genes in the gorilla and man
###end article-title 83
###begin article-title 84
Spontaneous fusion between normal host and tumor cells: possible contribution to tumor progression and metastasis studied with a lectin-resistant mutant tumor
###end article-title 84
###begin article-title 85
###xml 42 47 <span type="species:ncbi:9606">human</span>
Cyclic AMP-dependent protein kinasees and human trophoblast cell differentiation in vitro
###end article-title 85
###begin article-title 86
Continuous cultures of fused cells secreting antibody of predefined specificity
###end article-title 86
###begin article-title 87
###xml 79 108 <span type="species:ncbi:11801">Moloney murine leukemia virus</span>
Genistein, a protein tyrosine kinase inhibitor, suppresses the fusogenicity of Moloney murine leukemia virus envelope protein in XC cells
###end article-title 87
###begin article-title 88
Suggestive evidence that the highly metastatic variant ESb of the T-cell lymphoma Eb is derived from spontaneous fusion with a host macrophage
###end article-title 88
###begin article-title 89
Acquisition of high metastatic capacity after in vitro fusion of a nonmetastatic tumor line with a bone marrow-derived macrophage
###end article-title 89
###begin article-title 90
Syncytin and cancer cell fusions
###end article-title 90
###begin article-title 91
Prognostic role of syncytin expression in breast cancer
###end article-title 91
###begin article-title 92
###xml 29 56 <span type="species:ncbi:11827">human endogenous retrovirus</span>
The envelope glycoprotein of human endogenous retrovirus type W uses a divergent family of amino acid transporters/cell surface receptors
###end article-title 92
###begin article-title 93
###xml 51 55 <span type="species:ncbi:10090">mice</span>
Severely reduced female fertility in CD9-deficient mice
###end article-title 93
###begin article-title 94
###xml 42 47 <span type="species:ncbi:10090">mouse</span>
Tetraspanin CD9 regulates invasion during mouse embryo implantation
###end article-title 94
###begin article-title 95
###xml 0 27 <span type="species:ncbi:11827">Human endogenous retrovirus</span>
Human endogenous retrovirus-FRD envelope protein (syncytin 2) expression in normal and trisomy 21-affected placenta
###end article-title 95
###begin article-title 96
Placental syncytins: genetic disjunction between the fusogenic and immunosuppressive activity of retroviral envelope proteins
###end article-title 96
###begin article-title 97
###xml 62 67 <span type="species:ncbi:9606">human</span>
Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis
###end article-title 97
###begin article-title 98
Motility related protein 1 (MRP-1/CD9) expression: inverse correlation with metastases in breast cancer
###end article-title 98
###begin article-title 99
Spontaneous fusion between cancer cells and endothelial cells
###end article-title 99
###begin article-title 100
Biological implications of cell fusion
###end article-title 100
###begin article-title 101
Cell fusion during development
###end article-title 101
###begin article-title 102
A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion
###end article-title 102
###begin article-title 103
Tumour cell hybridization and metastasis revisited
###end article-title 103
###begin article-title 104
Tumor-cell fusion as a source of myeloid traits in cancer
###end article-title 104
###begin article-title 105
Syncytin: the major regulator of trophoblast fusion? Recent developments and hypotheses on its action
###end article-title 105
###begin article-title 106
Melanoma x macrophage hybrids with enhanced metastatic potential
###end article-title 106
###begin article-title 107
Bone marrow-derived cells fuse with normal and transformed intestinal stem cells
###end article-title 107
###begin article-title 108
Identification of an inducible surface molecule specific to fusing macrophages
###end article-title 108
###begin article-title 109
MFR a putative receptor mediating the fusion of macrophages
###end article-title 109
###begin article-title 110
EWI-2 and EWI-F link the tetraspanin web to the actin cytoskeleton through direct association with ezrin-radixin-moesin proteins
###end article-title 110
###begin article-title 111
###xml 29 34 <span type="species:ncbi:9606">human</span>
Suppression of malignancy in human cells
###end article-title 111
###begin article-title 112
Lymphoma-specific genetic abberations in microvascular endothelial cells in B-cell lymphomas
###end article-title 112
###begin article-title 113
###xml 79 84 <span type="species:ncbi:9606">human</span>
Proliferation and cell-cell fusion of endometrial carcinoma are induced by the human endogenous retroviral syncytin-1 and regulated by TGF-beta
###end article-title 113
###begin article-title 114
Role of transmembrane 4 superfamily (TM4SF) proteins CD9 and CD81 in muscle cell fusion and myotube maintenance
###end article-title 114
###begin article-title 115
Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma
###end article-title 115
###begin article-title 116
A nomenclature for signal regulatory protein family members
###end article-title 116
###begin article-title 117
Transplanted bone marrow regenerates liver by cell fusion
###end article-title 117
###begin article-title 118
Macrophage fusion: are somatic and cancer cells possible partners?
###end article-title 118
###begin article-title 119
###xml 72 78 <span type="species:ncbi:10090">murine</span>
Efficient spontaneous fusion between some co-cultured cells, especially murine melanoma cells
###end article-title 119
###begin article-title 120
Tumor-host cell hybrids in radiochimeras
###end article-title 120
###begin article-title 121
Cell fusion is the principal source of bone marrow-derived hepatocytes
###end article-title 121
###begin article-title 122
The analysis of malignancy by cell fusion. V. Further evidence of the ability of normal diploid cells to suppress malignancy
###end article-title 122
###begin article-title 123
SNAREpins: minimal machinery for membrane fusion
###end article-title 123
###begin article-title 124
A metalloproteinase-disintegrin participating in myoblast fusion
###end article-title 124
###begin article-title 125
DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells
###end article-title 125
###begin article-title 126
Donor Y chromosome in renal carcinoma cells of a female BMT recipient: visualization of putative BMT-tumor hybrids by FISH
###end article-title 126
###begin article-title 127
GCMa regulates the syncytin-mediated trophoblast fusion
###end article-title 127
###begin article-title 128
###xml 117 122 <span type="species:ncbi:9606">human</span>
###xml 127 132 <span type="species:ncbi:10090">mouse</span>
CD9 controls the formation of clusters that contain tetraspanins and the integrin alpha6beta1, which are involved in human and mouse gamete fusion
###end article-title 128

